The number of subjects undergoing major noncardiac surgery who are at risk for
perioperative myocardial infarction (MI) is growing worldwide.
It has been estimated that 500,000 to 900,000 patients suffer major perioperative cardiovascular complications every year, with consequent heavy, long-term prognostic implications and costs.
It is well known that perioperative MIs don’t share the same pathophysiology as nonsurgical MIs but the relative role of the different, potential triggers has not been completely clarified.
Many aspects of the perioperative management, including risk-stratification and prophylactic or postoperative interventions have also not been completely defined.
Throughout recent years many resources have been invested to clarify these aspects and experts have developed indices and algorithm-based strategies to better assess the cardiac risk and to guide the perioperative management.
The scope of the present review is to discuss the main aspects of perioperative MI in noncardiac surgery, with particular regard to epidemiology, pathophysiology, preoperative risk stratification, prophylaxis and therapy. (Heart International 2006; 2: 82-93)
Myocardial infarction, Noncardiac surgery, Cardiac risk
Dr. Stefano Lucreziotti, U.O. Cardiologia, Azienda Ospedaliera S. Paolo, Via di Rudinì, 8, 20142 Milano, email@example.com
Share this Article
Related Content In Cardiovascular Disease
ST-elevation Myocardial Infarction and Multivessel Coronary Artery Disease – A Critical Review of Current Practice, Evidence and Meta-analyses
Heart International. 2020;14(2):80-5 DOI: https://doi.org/10.17925/HI.2020.14.2.80
Reperfusion of infarct-related artery (IRA) in acute ST-elevation myocardial infarction (STEMI) is the procedure with the most clinical benefit in interventional cardiology. However, in around 50% of patients presenting with STEMI, other significant lesions are present, a finding which is associated to a worse prognosis.1,2 Most physicians performing primary percutaneous coronary intervention (PCI) have been trained […]
The Role of Transoesophageal Echocardiography in Surgical Removal of a Mediastinal Tumour
Heart International. 2020;14(2):118-20 DOI: https://doi.org/10.17925/HI.2020.14.2.118
Perioperative management of a mediastinal tumour is an anaesthetic challenge. Echocardiography is not considered as a primary diagnostic modality in the evaluation of a mediastinal mass; however, it can provide valuable information in patients with clinical and diagnostic evidence of cardiac compression or encroachment. Judicious interpretation of perioperative transthoracic or transoesophageal echocardiographic images may be […]
Ratio of Serum Aspartate to Alanine Aminotransferase as a Marker of Isolated Coronary Artery Ectasia and its Severity
Heart International. 2020;14(1):43–8 DOI: https://doi.org/10.17925/HI.2020.14.1.43
The exact aetiology of coronary artery ectasia (CAE) has yet to be fully elucidated; however, some underlying aetiologies such as atherosclerosis and microvascular abnormalities in coronary arteries have been proposed.1,2 Over the past few years, several inflammatory markers have been introduced as indicators of CAE and its severity. There is an association between the development of […]
Journal articles and more to your inbox
Get the latest clinical insights from touchCARDIOSign me up!